Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Francesca Bruce
The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates and patent research exemptions.
Colombia’s health ministry has accused the R&D-based pharmaceutical industry association of prioritizing monopolies over patients after its attempts to suspend legislation that promises a faster route to market for biosimilars.
Australia’s regulator has responded to consultation submissions and is moving forward with plans to issue guidance on biovigilance.
A new methodology for evaluating the benefits of new medicines aims to make funding decisions more transparent and structured. It could also offer an alternative to the way health technology appraisals reflect value.
Strengthening Brazil’s policy on orphan drugs would help stem the number of court cases brought by patients to access medicines, says Alexion.
Janssen’s commitment to invest more in clinical research in Argentina could be a sign that new regulations are bringing back clinical research to the country.